[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352351-105":59,"doc-detail-352351-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","identification-of-putative-causal-associations-between-micrornas-and-breast-cancer-via-mendelian-randomization-and-bioinformatic-analysis","Identification of putative causal associations between MicroRNAs and breast cancer via Mendelian randomization and bioinformatic analysis","","MicroRNAs (miRNAs) are implicated in breast cancer progression and prognosis. This observational study used a Mendelian randomization framework to test causal relationships between plasma circulating miRNAs and breast cancer. miRNA eQTLs were extracted from two independent cohorts, and high-confidence miRNAs with associated SNPs were analyzed by two-sample MR using inverse-variance weighted and MR-Egger. Differential expression and univariate Cox regression identified survival-linked genes, while enrichment analyses mapped pathways and processes linked to candidate targets, with pan-cancer validation using ENCORI.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/identification-of-putative-causal-associations-between-micrornas-and-breast-cancer-via-mendelian-randomization-and-bioinformatic-analysis/352351/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/identification-of-putative-causal-associations-between-micrornas-and-breast-cancer-via-mendelian-randomization-and-bioinformatic-analysis/352351.png","ImageObject",300,407,{"name":92,"@type":93},"Noah","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main purpose of this study?","Question",{"text":112,"@type":113},"To identify putative causal associations between plasma circulating microRNAs and breast cancer using Mendelian randomization and bioinformatic analyses.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were miRNAs and genetic instruments selected for Mendelian randomization?",{"text":117,"@type":113},"miRNA expression quantitative trait loci were extracted from two independent cohorts, and high-confidence miRNAs with associated SNPs were selected for two-sample MR using inverse-variance weighted and MR-Egger methods.",{"name":119,"@type":110,"acceptedAnswer":120},"Which miRNAs showed protective associations in the discovery and validation phases?",{"text":121,"@type":113},"In the discovery phase, hsa-miR-100-5p, hsa-miR-125b-5p, and hsa-miR-339-5p were significantly associated with reduced breast cancer risk (P \u003C .05). In the validation cohort, only hsa-miR-339-5p confirmed a protective effect, while hsa-miR-100-5p and hsa-miR-125b-5p were not significant.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352351,1790144276,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},8796095462418,"https://ap-avatar.wpscdn.com/avatar/80000253c1241d02b47?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778826106357471780","®  \n Observational Study   \nIdentification of putative causal associations between MicroRNAs and breast cancer via Mendelian randomization and bioinformatic analysis  \nJianlin Ren, BDa , Lifeng Zhu, BDa ,*  \n\n| Abstract\u003Cbr>MicroRNAs (miRNAs) are implicated in breast cancer progression and prognosis. This study employed a Mendelian randomization (MR) framework to investigate causal relationships between plasma circulating miRNAs and breast cancer. miRNA expression quantitative trait loci were extracted from 2 independent cohorts. High-confidence miRNAs and their associated single-nucleotide polymorphisms were selected for 2-sample MR analyses using inverse-variance weighted and MR-Egger methods. Differential expression analysis and univariate Cox regression identified survival-associated genes in breast cancer, while enrichment analyses revealed pathways and biological processes linked to candidate targets. Pan-cancer analyses of miRNAs and targets were conducted via the ENCORI platform. Initial MR analyses in the discovery phase identified hsa-miR-100-5p, hsa-miR-125b-5p, and hsa-miR-339-5p as significantly associated with reduced breast cancer risk (P \u003C .05), suggesting potential protective roles. A total of 1291 survival-associated differentially expressed genes were identified, with 39 overlapping targets implicated in miRNAmediated breast cancer intervention. Enrichment analyses highlighted their involvement in cell cycle regulation and p53 signaling pathway. In the validation cohort, only hsa-miR-339-5p confirmed a protective effect on breast cancer risk, while hsa-miR- 100-5p and hsa-miR-125b-5p did not reach significance. Pan-cancer profiling demonstrated aberrant miRNA expression across malignancies, prognostic relevance in multiple cancers, and significant negative correlations between miRNAs and target genes in breast tumors. Our findings provide novel insights into the causal roles of miRNAs in breast cancer pathogenesis and underscore their potential as noninvasive biomarkers and therapeutic targets. Future studies should prioritize functional validation and clinical translation of these miRNAs. |\n| --- |\n| Abbreviations: DEG = differentially expressed gene, eQTL = expression quantitative trait loci , FDR = false discovery rate, GWAS = genome-wide association studies, IVW = inverse-variance weighted, miRNA = MicroRNA, MR = Mendelian randomization, OR = odds ratio, SNP = single nucleotide polymorphism, TCGA = The Cancer Genomic Atlas. |\n| Keywords: breast cancer, cell cycle, Mendelian randomization, miRNA, quantitative trait loci |\n\n1. Introduction  \nBreast cancer stands as one of the most common malignancies among women globally, with its incidence and mortality rates continuing to rise in many countries. [1] According to statistics from the World Health Organization, breast cancer has become a leading cause of cancer-related deaths among women. [1] Despite significant advances in early screening and treatment methods that have notably improved survival rates for patients with breast cancer in recent years, numerous challenges remain,  \nincluding disease heterogeneity,[2] risk of recurrence,[3] and resistance to existing therapies.[4] Therefore, a deeper understanding of the mechanisms underlying breast cancer development and associated risk factors is crucial for devising effective prevention and treatment strategies.  \nMicroRNAs (miRNAs), a class of ~22-nucleotide noncoding RNA molecules, are widely involved in the regulation of gene expression. Research has demonstrated that miRNAs impact biological processes such as cell proliferation, differentiation, and apoptosis by targeting specific gene expressions. [5]  \nInstitutional review board approval and informed consent were not required in the current study because research data are publicly available and all patient data are de-identified.  \nThe authors have no funding and conflicts of interest to disclose. The datasets generated during and/or analyzed during th","cbCaicGHZ4L93Km8","https://ap.wps.com/l/cbCaicGHZ4L93Km8","pdf",2508756,"English","# Introduction\n## Background on breast cancer and key challenges\n## Role of microRNAs in gene regulation\n## Study aims and data availability notes","[{\"question\":\"What was the main purpose of this study?\",\"answer\":\"To identify putative causal associations between plasma circulating microRNAs and breast cancer using Mendelian randomization and bioinformatic analyses.\"},{\"question\":\"How were miRNAs and genetic instruments selected for Mendelian randomization?\",\"answer\":\"miRNA expression quantitative trait loci were extracted from two independent cohorts, and high-confidence miRNAs with associated SNPs were selected for two-sample MR using inverse-variance weighted and MR-Egger methods.\"},{\"question\":\"Which miRNAs showed protective associations in the discovery and validation phases?\",\"answer\":\"In the discovery phase, hsa-miR-100-5p, hsa-miR-125b-5p, and hsa-miR-339-5p were significantly associated with reduced breast cancer risk (P \\u003c .05). In the validation cohort, only hsa-miR-339-5p confirmed a protective effect, while hsa-miR-100-5p and hsa-miR-125b-5p were not significant.\"}]","Identification of putative causal associations between MicroRNAs and breast cancer via Mendelian randomization and bioinformatic analysis | PDF",1790099126,25,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2c2c9d94d459948b0a63116493b43667.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50a3925be7281eda0f17ff2aa2a40b6e.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/076bb2ed3b795d66cba2c576db90b23f.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a4226495917ae4b9c704cb5db60229a1.webp",980,1306]